Unknown

Dataset Information

0

Binding characterization of N-(2-chloro-5-thiomethylphenyl)-N'-(3-[3 H]3 methoxy phenyl)-N'-methylguanidine ([3 H]GMOM), a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist.


ABSTRACT: Labeled with carbon-11, N-(2-chloro-5-thiomethylphenyl)-N'-(3-methoxyphenyl)-N'-methylguanidine ([11 C]GMOM) is currently the only positron emission tomography (PET) tracer that has shown selectivity for the ion-channel site of N-methyl-D-aspartate (NMDA) receptors in human imaging studies. The present study reports on the selectivity profile and in vitro binding properties of GMOM. The compound was screened on a panel of 80 targets, and labeled with tritium ([3 H]GMOM). The binding properties of [3 H]GMOM were compared to those of the reference ion-channel ligand [3 H](+)-dizocilpine maleate ([3 H]MK-801), in a set of concentration-response, homologous and heterologous inhibition, and association kinetics assays, performed with repeatedly washed rat forebrain preparations. GMOM was at least 70-fold more selective for NMDA receptors compared to all other targets examined. In homologous inhibition and concentration-response assays, the binding of [3 H]GMOM was regulated by NMDA receptor agonists, albeit in a less prominent manner compared to [3 H]MK-801. Scatchard transformation of homologous inhibition data produced concave upward curves for [3 H]GMOM and [3 H]MK-801. The radioligands showed bi-exponential association kinetics in the presence of 100 ?mol L-1 l-glutamate/30 ?mol L-1 glycine. [3 H]GMOM (3 nmol L-1 and 10 nmol L-1 ) was inhibited with dual affinity by (+)-MK-801, (R,S)-ketamine and memantine, in both presence and absence of agonists. [3 H]MK-801 (2 nmol L-1 ) was inhibited in a monophasic manner by GMOM under baseline and combined agonist conditions, with an IC50 value of ~19 nmol L-1 . The non-linear Scatchard plots, biphasic inhibition by open channel blockers, and bi-exponential kinetics of [3 H]GMOM indicate a complex mechanism of interaction with the NMDA receptor ionophore. The implications for quantifying the PET signal of [11 C]GMOM are discussed.

SUBMITTER: Metaxas A 

PROVIDER: S-EPMC6381215 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Binding characterization of N-(2-chloro-5-thiomethylphenyl)-N'-(3-[<sup>3</sup> H]<sub>3</sub> methoxy phenyl)-N'-methylguanidine ([<sup>3</sup> H]GMOM), a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist.

Metaxas Athanasios A   van Berckel Bart N M BNM   Klein Pieter J PJ   Verbeek Joost J   Nash Emily C EC   Kooijman Esther J M EJM   Renjaän Véronique A VA   Golla Sandeep S V SSV   Boellaard Ronald R   Christiaans Johannes A M JAM   Windhorst Albert D AD   Leysen Josée E JE  

Pharmacology research & perspectives 20190201 1


Labeled with carbon-11, N-(2-chloro-5-thiomethylphenyl)-N'-(3-methoxyphenyl)-N'-methylguanidine ([<sup>11</sup> C]GMOM) is currently the only positron emission tomography (PET) tracer that has shown selectivity for the ion-channel site of N-methyl-D-aspartate (NMDA) receptors in human imaging studies. The present study reports on the selectivity profile and in vitro binding properties of GMOM. The compound was screened on a panel of 80 targets, and labeled with tritium ([<sup>3</sup> H]GMOM). Th  ...[more]

Similar Datasets

| S-EPMC5788303 | biostudies-literature
| S-EPMC2983947 | biostudies-literature
| S-EPMC3274996 | biostudies-literature
2020-01-13 | GSE47601 | GEO
| S-EPMC2865314 | biostudies-literature
| S-EPMC2980227 | biostudies-literature
| S-EPMC2959501 | biostudies-literature
| S-EPMC2915044 | biostudies-literature
| S-EPMC2962023 | biostudies-literature
| S-EPMC2962144 | biostudies-literature